GlobalHealth policy
International Pediatric Nephrology Association publishes diagnosis and treatment recommendations for aHUS in children
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
The International Pediatric Nephrology Association published its recommendations for diagnosing and treating atypical HUS in children. The recommendations were prepared through the consensus of international experts from different fields. The document contains 51 recommendations and 9 practice points. Genetic and autoimmune aHUS and aHUS after kidney transplantation are addressed separately. The recommendations were also written with the conditions of countries with limited resources in mind.
What does it mean for patients and families?
The recommendations help pediatric kidney doctors follow a common approach to diagnosis and treatment. Each child's treatment is planned with their own doctor.
Source
Scientific paper: IPNA clinical practice recommendations for the management of aHUS and secondary TMA in children. Pediatric Nephrology, 2026. DOI: 10.1007/s00467-026-07537-7 · PubMed 42776239
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Atypical hemolytic uremic syndrome (aHUS)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.